U.S., Oct. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07203833) titled 'Diagnostic and Prognostic Evaluation of Vasorin During Septic Shock' on Sept. 25.
Brief Summary: Septic shock is the most severe form of infection. Currently, an early specific biomarker for septic shock is needed. Remember that shock situations are numerous, not only septic (eg hemorrhagic, cardiogenic...), and also accompanied by a severe pro-inflammatory state that it is sometimes difficult to distinguish from a septic state. Procalcitonin (PCT) is the most studied biomarker but still lacks sensitivity (77%) and specificity (79%). The investigators hypothesize that the Vasn could become this potential new biomarker and would allow...